Childhood immunisation against S. pneumoniae is the most effective public health measure for preventing IPD both among vaccine recipients (direct effect), and among unimmunised populations (indirect ‘herd’ effect).
Immunisation is the only effective method of prevention. Mumps vaccine is given in the form of the combined trivalent measles-mumps-rubella (MMR) vaccine in all European countries with a first dose at or before 18 months of age. The timing of the second dose varies across countries.
Immunisation is the only effective prevention of tetanus. Tetanus toxoid is an effective, safe, stable and inexpensive vaccine that can be given to all ages, to pregnant women and to immunocompromised individuals.
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
Organized by:World Health Organization (WHO) - Regional office for Europe
European Immunization Week (EIW) is celebrated across the European Region every April to raise awareness of the importance of immunization for people’s health and well-being. Under the slogan "Vaccines work" EIW 2017 focused on the need for and benefits of immunization at every stage in life.
The aim of this research project is to have a better understanding of vaccine hesitancy and safety concerns among healthcare vaccine providers and their patients in Europe and to explore the link and potential influence between the two groups.
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
Organized by:World Health Organization (WHO) - Regional office for Europe
This report summarizes the conclusions of an interview study with public health authorities in Europe and Central Asia, exploring the barriers and drivers to advancing the use of behavioural and cultural insights (BCI) for health.